News & Publications

Press Releases and Statements

Animal Health Institute Statement on White House Forum for Antibiotic Stewardship

Washington, DC – Animal health companies are pleased to have the opportunity to participate in today’s White House Forum for Antibiotic Stewardship bringing together some 150 representatives from both human and animal health. Healthy animals mean healthy people, which is why the Animal Health Institute (AHI) supports a collaborative, broad-based approach to keeping animals and […]

Read more »

AHI Statement on FDA Proposed Rule on Antibiotic Sales Data

Washington, D.C. – Animal health companies have been complying with the provisions of ADUFA Section 105 since 2008 by providing annual antibiotic sales data for food producing animals to the Food and Drug Administration. Today’s proposed regulation expands on those requirements. The Animal Health Institute has always supported the collection and use of data that […]

Read more »

AHI Statement on Tyson Foods Antibiotic Policy

Washington, D.C. – Animal health companies are committed to implementation of the FDA judicious use policy requiring the elimination of growth promotion uses of medically important antibiotics and requiring veterinary supervision for all remaining uses.    As a result, these antibiotics will be used only to fight disease under the supervision of a veterinarian.  Along with […]

Read more »

Animal Health Institute Statement on NARMS Retail Meat Results

Washington, D.C. – Today’s National Antimicrobial Resistance Monitoring System’s 2012 Retail Meat report is significant and welcome. It shows that antibiotics can and are being used to effectively keep food animals healthy while minimizing the potential for transfer of resistant bacteria from animals to people. Antibiotic resistant is a major health concern, and the Centers […]

Read more »

Animal Healthcare Product Sales Stable in 2013

Media Contact: Ron Phillips: (202) 637-2440 Washington, D.C., January 14, 2015 – Spending by Americans on medicines used to protect the health of companion and farm animals was essentially unchanged in 2013 compared to 2012, not adjusted for inflation, according to figures released today by the Animal Health Institute. Sales for medicines for pets and […]

Read more »

AHI Statement on PEW Report on FDA Judicious Use Policy

Implementation of The Food and Drug Administration’s judicious use policy means medically important antibiotics will be used in food animals only to fight disease under the supervision of a licensed veterinarian. There is no loophole. The Pew report alleging that growth promotion uses might continue is wrong. There are 82 growth promotion claims that will […]

Read more »

AHI Statement on FDA Sales Data Report

Media Contact:           Ron Phillips:    (202) 637-2440 WASHINGTON, DC, October 2, 2014 – Today’s antibiotic sales data report from the Food and Drug Administration (FDA) is a small part of the story about the public health impact of antibiotics used to keep food animals healthy. National sales information is limited in its use and does […]

Read more »

AHI Comment on PCAST Report on Antibiotic Resistance

Antibiotic resistance is a serious public health threat. Like the 2013 Centers for Disease Control and Prevention (CDC) report on antibiotic resistance, President Obama’s Council of Advisors on Science and Technology (PCAST) report provides an important perspective and context on antibiotic resistance and the role of both human and animal medicine. The Animal Health Institute […]

Read more »

AHI Response to Reuters Story on Antibiotic Use in Chicken

Antibiotics are important tools used by producers and veterinarians to keep food animals healthy, which is essential to maintaining a healthy food supply. It is important to remember that they are only one of several tools and practices used. Animal health companies, producers and veterinarians work hard to minimize the need for antibiotics, use them […]

Read more »

AHI Statement on Second Circuit Court of Appeals Decision upholding FDA action on Judicious use of Antibiotics

Today’s Second Circuit Court of Appeals decision supporting the Food and Drug Administration’s (FDA) decision to pursue a collaborative stakeholder process to implement significant changes to antibiotic use rather than a regulatory action is a welcome development.  The court joins the Center for Disease Control and the President’s Council of Advisors on Science and Technology […]

Read more »